“Accord Clinical Research seeks participants for clinical research trials in the metro-area of Daytona Beach, Florida”
Port Orange, FL, April 28, 2010 — Accord Clinical Research, located in Port Orange, Florida, is currently seeking qualified participants to take part in a clinical research study to test investigational treatments for patients diagnosed with ulcerative proctitis disease.
Ulcerative proctitis is characterized by swelling, redness, and ulcerations of the lining of the rectum (the rectum is the last seven inches of the large intestine). The word “ulcerative” is used because the disease actually causes the formation of sores on the inner lining of the rectum. To date, the cause of ulcerative proctitis is unknown. Although it is unclear what causes ulcerative proctitis, it is known that dietary habit and stress are not causal factors. People with busier and more stressful lives do tend to have aggravated symptoms.
“Many researchers believe that a possible virus causes a reaction of the body’s immune system,” states Dr. Ricci, MD, of Accord Clinical Research. “The lining of the rectum becomes inflamed, creating diarrhea, bleeding, mucus and rectal pain. Patients sometimes will experience the passage of blood or mucus with or without their stool. Although the level of bleeding from ulcerative proctitis is typically small, it can appear to be a lot, which can be frightening. All of these symptoms can occur without warning at any time during the day or night.”
Qualified participants must be eighteen years of age or older, without a history of alcohol or substance abuse within the past five years, have not been part of an investigational study within the past thirty days, and have already been diagnosed with ulcerative proctitis or UP.
Accord Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications at no charge. Participants will also be compensated for time and travel up to $475. For more information regarding participation in our research studies, contact Accord Clinical Research at 386.760.7272, or at www.AccordClinical.com.